RNF220 mediates medulloblastoma development by epigenetic modulation of Shh signal pathway [5], as well as accelerates the leukemic cells proliferation and declines the Cyclin D1 protein degradation [8]. The gene discussed is RNF220; the disease is medulloblastoma.